Merck’s Molnupiravir Open License With Medicines Patent Pool May Be Model

 
• By Brenda Sandburg
  
Molnupiravir
Merck licenses its COVID-19 drug molnupiravir to the Medicines Patent Pool • Source: Alamy
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Pink Sheet